SSA
IRWD icon

Schonfeld Strategic Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Schonfeld Strategic Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$205K Buy
+58,377
New +$239K ﹤0.01% 1734
2025
Q2 		– Sell
-307,337
Closed -$452K – 2271
2025
Q1 		$452K Buy
307,337
+52,297
+21% +$125K ﹤0.01% 1625
2024
Q4 		$1.13M Buy
255,040
+73,447
+40% +$298K 0.01% 1064
2024
Q3 		$748K Sell
181,593
-165,447
-48% -$889K 0.01% 1263
2024
Q2 		$2.26M Sell
347,040
-965,204
-74% -$6.83M 0.01% 858
2024
Q1 		$11.4M Buy
1,312,244
+1,239,268
+1,698% +$15M 0.08% 328
2023
Q4 		$835K Buy
72,976
+40,576
+125% +$401K 0.01% 1096
2023
Q3 		$312K Sell
32,400
-188,878
-85% -$1.85M ﹤0.01% 1317
2023
Q2 		$2.35M Buy
+221,278
New +$2.38M 0.02% 700
2023
Q1 		– Sell
-24,700
Closed -$306K – 2348
2022
Q4 		$306K Sell
24,700
-121,863
-83% -$1.38M ﹤0.01% 1780
2022
Q3 		$1.52M Buy
+146,563
New +$1.66M 0.01% 1012
2022
Q1 		– Sell
-40,200
Closed -$469K – 2743
2021
Q4 		$469K Buy
40,200
+3,200
+9% +$39.3K ﹤0.01% 1297
2021
Q3 		$484K Sell
37,000
-10,118
-21% -$131K 0.01% 1290
2021
Q2 		$607K Buy
+47,118
New +$539K 0.01% 1101
2020
Q2 		– Sell
-21,677
Closed -$219K – 1382
2020
Q1 		$219K Buy
21,677
+7,054
+48% +$82.9K 0.01% 880
2019
Q4 		$195K Buy
14,623
+3,723
+34% +$41K ﹤0.01% 1172
2019
Q3 		$94K Buy
+10,900
New +$106K ﹤0.01% 951
2018
Q2 		– Sell
-90,977
Closed -$1.18M – 852
2018
Q1 		$1.18M Buy
+90,977
New +$1.13M 0.09% 289
2017
Q3 		– Sell
-90,041
Closed -$1.42M – 683
2017
Q2 		$1.42M Sell
90,041
-239,159
-73% -$3.48M 0.15% 205
2017
Q1 		$4.7M Buy
329,200
+113,228
+52% +$1.55M 0.47% 50
2016
Q4 		$2.77M Buy
+215,972
New +$2.73M 0.36% 75

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Schonfeld Strategic Advisors's IRWD Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 58,377 shares worth $205K. The stake represents ﹤0.01% of the portfolio and ranks #1734 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in IRWD as recently as Q1 2025.

Schonfeld Strategic Advisors first reported a position in IRWD in Q4 2016 and has held it in 21 quarters since. The position peaked at $11.4M in Q1 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Schonfeld Strategic Advisors held 58,377 shares of Ironwood Pharmaceuticals worth $205K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1734 holding.
  • Schonfeld Strategic Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2016 and has held it in 21 quarters since.
  • Schonfeld Strategic Advisors's Ironwood Pharmaceuticals position peaked at $11.4M in Q1 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.